GREEN CROSS WellBeing Corporation (KQ:234690) — Market Cap & Net Worth

$130.36 Million USD  · ₩192.36 Billion KRW  · Rank #18214

Market Cap & Net Worth: GREEN CROSS WellBeing Corporation (234690)

GREEN CROSS WellBeing Corporation (KQ:234690) has a market capitalization of $130.36 Million (₩192.36 Billion) as of October 11, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18214 globally and #829 in its home market, demonstrating a 16.94% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying GREEN CROSS WellBeing Corporation's stock price ₩10840.00 by its total outstanding shares 17745166 (17.75 Million).

GREEN CROSS WellBeing Corporation Market Cap History: 2019 to 2026

GREEN CROSS WellBeing Corporation's market capitalization history from 2019 to 2026. Data shows change from $122.18 Million to $130.36 Million (-1.38% CAGR). Check current stock price of GREEN CROSS WellBeing Corporation for real-time trading data and today's change.

Index Memberships

GREEN CROSS WellBeing Corporation is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
Kosdaq Composite Index
KOSDAQ
$256.78 Billion 0.05% #321 of 1384
Kosdaq Composite Index
KQ11
$256.78 Billion 0.05% #321 of 1384

Weight: GREEN CROSS WellBeing Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

GREEN CROSS WellBeing Corporation Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how GREEN CROSS WellBeing Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see 234690 cash flow metrics for how efficiently the company converts equity into cash flow.

Latest Price to Sales (P/S) Ratio

0.00x

GREEN CROSS WellBeing Corporation's market cap is 0.00 times its annual revenue

Industry average: 4260.63x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.01x

GREEN CROSS WellBeing Corporation's market cap is 0.01 times its annual earnings

Industry average: 1.60x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2019 $122.18 Million $66.94 Billion $5.70 Billion 0.00x 0.02x
2020 $162.75 Million $75.60 Billion $1.53 Billion 0.00x 0.11x
2021 $118.93 Million $90.97 Billion $6.70 Billion 0.00x 0.02x
2022 $97.58 Million $109.73 Billion $8.00 Billion 0.00x 0.01x
2023 $97.77 Million $120.53 Billion $6.75 Billion 0.00x 0.01x
2024 $120.98 Million $133.80 Billion $7.07 Billion 0.00x 0.02x
2025 $109.91 Million $164.68 Billion $10.01 Billion 0.00x 0.01x

Competitor Companies of 234690 by Market Capitalization

Companies near GREEN CROSS WellBeing Corporation in the global market cap rankings as of October 11, 2026. See how leveraged is GREEN CROSS WellBeing Corporation's balance sheet to understand what proportion of total assets are financed by equity.

Key companies related to GREEN CROSS WellBeing Corporation by market ranking:

  • Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $129.29 Billion USD.
  • Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #366 globally with a market cap of $75.50 Billion USD.
  • CSL Ltd (AU:CSL): Ranked #448 globally with a market cap of $63.11 Billion USD ( AU$89.19 Billion AUD).
  • Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#185 Vertex Pharmaceuticals Inc NASDAQ:VRTX $129.29 Billion $510.08
#366 Regeneron Pharmaceuticals Inc NASDAQ:REGN $75.50 Billion $746.54
#448 CSL Ltd AU:CSL $63.11 Billion AU$183.84
#506 Moderna Inc NASDAQ:MRNA $54.14 Billion $225.00

GREEN CROSS WellBeing Corporation Historical Marketcap From 2019 to 2026

Between 2019 and today, GREEN CROSS WellBeing Corporation's market cap moved from $122.18 Million to $ 130.36 Million, with a yearly change of -1.38%.

Year Market Cap Change (%)
2026 ₩130.36 Million +18.60%
2025 ₩109.91 Million -9.15%
2024 ₩120.98 Million +23.74%
2023 ₩97.77 Million +0.20%
2022 ₩97.58 Million -17.96%
2021 ₩118.93 Million -26.92%
2020 ₩162.75 Million +33.21%
2019 ₩122.18 Million --

End of Day Market Cap According to Different Sources

On Oct 10th, 2026 the market cap of GREEN CROSS WellBeing Corporation was reported to be:

Source Market Cap
Yahoo Finance $130.36 Million USD
MoneyControl $130.36 Million USD
MarketWatch $130.36 Million USD
marketcap.company $130.36 Million USD
Reuters $130.36 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About GREEN CROSS WellBeing Corporation

KQ:234690 Korea Biotechnology
Market Cap
$130.36 Million
₩192.36 Billion KRW
Market Cap Rank
#18214 Global
#829 in Korea
Share Price
₩10840.00
Change (1 day)
-0.55%
52-Week Range
₩7250.00 - ₩15100.00
All Time High
₩16468.03
About

GC WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. The company was formerly known as GREEN CROSS WellBeing Corporation and changed its name to GC WellBeing Corporation in April 2026. The company was founded in … Read more